Clinical Trials

Neurology

11 drugs in development·9 companies·2 clinical trials

Drug Pipeline by Phase

Approved(8)

Drug	Company
atomoxetine	Aptinyx Inc. (APTX)
atomoxetine	DR REDDYS LABORATORIES LTD (RDY)
atomoxetine	Teva Pharmaceutical Industries Limited (TEVA)
atomoxetine	SUNSET ISLAND GROUP (SUN)
buspirone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
edluar	Viatris Inc (VTRS)
venlafaxine	Teva Pharmaceutical Industries Limited (TEVA)
zolpidem	Teva Pharmaceutical Industries Limited (TEVA)

Phase 1(1)

Drug	Company
prulacabtagene leucel (prula-cel	Adicet Bio, Inc. (ACET)

Unknown(2)

Drug	Company
Alpha Research Institute	Cannabis Bioscience International Holdings, Inc. (CBIH)
clonoSEQ assay (MRD Pharma)	Adaptive Biotechnologies Corp (ADPT)

BioSniper tracks 11 drugs in development for Clinical Trials across 9 companies.

There are 2 clinical trials targeting Clinical Trials tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.